Fig 6.

Comparison of proportions of patients achieving improvement from baseline in European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Cancer Module (week 8/9). (A) Proportions were calculated including all patients with baseline questionnaires and counting those missing questionnaires at a subsequent time point as unimproved. (B) Patients with missing questionnaires after baseline were not included in the denominator. BEV, bevacizumab; CT, chemotherapy; QoL, quality of life.